N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine
C31H37FN2O2 — CID 155635089
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine
N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine (PubChem CID 155635089) has the molecular formula C31H37FN2O2 and a molecular weight of 488.65 g/mol. Its IUPAC name is N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine.
Molecular Properties
| Compound Name | N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine |
|---|---|
| PubChem CID | 155635089 |
| Molecular Formula | C31H37FN2O2 |
| Molecular Weight | 488.65 g/mol |
| Exact Mass | 488.28 |
| IUPAC Name | N-[2-[4-[[5-butoxy-3-fluoro-2-(2-methoxyphenyl)indol-1-yl]methyl]phenyl]ethyl]propan-1-amine |
| SMILES | CCCCOc1ccc2c(c1)c(F)c(-c1ccccc1OC)n2Cc1ccc(CCNCCC)cc1 |
| InChI | InChI=1S/C31H37FN2O2/c1-4-6-20-36-25-15-16-28-27(21-25)30(32)31(26-9-7-8-10-29(26)35-3)34(28)22-24-13-11-23(12-14-24)17-19-33-18-5-2/h7-16,21,33H,4-6,17-20,22H2,1-3H3 |
| InChIKey | FYCCXDXSMCGVIT-UHFFFAOYSA-N |
| XLogP | 7.23 |
| TPSA | 35.42 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 488.65 |
| LogP ≤ 5 | 7.23 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155635089 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.